Zhenhe Suo

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Retraction: PDHA1 gene knockout in prostate cancer cells results in metabolic reprogramming towards greater glutamine dependence.

Retraction: PDHA1 gene knockout in prostate cancer cells results in metabolic reprogramming towards greater glutamine dependence.

Journal: Oncotarget

Published: November 07, 2025

Promoting role of pentraxin-3 in esophageal squamous cell carcinoma.

Promoting role of pentraxin-3 in esophageal squamous cell carcinoma.

Journal: Molecular therapy oncolytics

Published: June 15, 2021

Corrigendum to "Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy" [Canc. Lett 244 (2006) 182-189].

Corrigendum to "Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy" [Canc. Lett 244 (2006) 182-189].

Journal: Cancer letters

Published: October 28, 2020

Correction: Potent and specific MTH1 inhibitors targeting gastric cancer.

Correction: Potent and specific MTH1 inhibitors targeting gastric cancer.

Journal: Cell death & disease

Published: October 17, 2020

Correction to Potent 5-Cyano-6-phenyl-pyrimidin-Based Derivatives Targeting DCN1-UBE2M Interaction.

Correction to Potent 5-Cyano-6-phenyl-pyrimidin-Based Derivatives Targeting DCN1-UBE2M Interaction.

Journal: Journal of medicinal chemistry

Published: September 30, 2020

Abrogation of USP7 is an alternative strategy to downregulate PD-L1 and sensitize gastric cancer cells to T cells killing.

Abrogation of USP7 is an alternative strategy to downregulate PD-L1 and sensitize gastric cancer cells to T cells killing.

Journal: Acta pharmaceutica Sinica. B

Published: June 21, 2020

Oncogenic Role of Guanylate Binding Protein 1 in Human Prostate Cancer.

Oncogenic Role of Guanylate Binding Protein 1 in Human Prostate Cancer.

Journal: Frontiers in oncology

Published: September 15, 2019

PDHA1 Gene Knockout In Human Esophageal Squamous Cancer Cells Resulted In Greater Warburg Effect And Aggressive Features In Vitro And In Vivo.

PDHA1 Gene Knockout In Human Esophageal Squamous Cancer Cells Resulted In Greater Warburg Effect And Aggressive Features In Vitro And In Vivo.

Journal: OncoTargets and therapy

Published: August 12, 2019

High level of lncRNA H19 expression is associated with shorter survival in esophageal squamous cell cancer patients.

High level of lncRNA H19 expression is associated with shorter survival in esophageal squamous cell cancer patients.

Journal: Pathology, research and practice

Published: July 20, 2019

Potent 5-Cyano-6-phenyl-pyrimidin-Based Derivatives Targeting DCN1-UBE2M Interaction.

Potent 5-Cyano-6-phenyl-pyrimidin-Based Derivatives Targeting DCN1-UBE2M Interaction.

Journal: Journal of medicinal chemistry

Published: June 04, 2019

Author Correction: PBX3 is targeted by multiple miRNAs and is essential for liver tumour-initiating cells.

Author Correction: PBX3 is targeted by multiple miRNAs and is essential for liver tumour-initiating cells.

Journal: Nature communications

Published: May 23, 2019

USP7: Novel Drug Target in Cancer Therapy.

USP7: Novel Drug Target in Cancer Therapy.

Journal: Frontiers in pharmacology

Published: January 28, 2019

Showing 1-12 of 60

Last Updated: 09/26/2026